chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle spasms in the shoulder of his right arm; His whole arm was stiff down to his hand; Shoulder and upper arm were swollen; Some other side effects; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms in the shoulder of his right arm), MUSCULOSKELETAL STIFFNESS (His whole arm was stiff down to his hand), PERIPHERAL SWELLING (Shoulder and upper arm were swollen) and VACCINATION COMPLICATION (Some other side effects) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Muscle spasms in the shoulder of his right arm), MUSCULOSKELETAL STIFFNESS (His whole arm was stiff down to his hand), PERIPHERAL SWELLING (Shoulder and upper arm were swollen) and VACCINATION COMPLICATION (Some other side effects). At the time of the report, MUSCLE SPASMS (Muscle spasms in the shoulder of his right arm), MUSCULOSKELETAL STIFFNESS (His whole arm was stiff down to his hand), PERIPHERAL SWELLING (Shoulder and upper arm were swollen) and VACCINATION COMPLICATION (Some other side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
pt recv vax & pt exp a rash on toes that itched & burned, lasting approx 4mo;pt recovered;
Within 2 days of getting the 2nd booster vaccine(my 4th vaccine shot) the fibromyalgia became severe and could not be controlled or mitigated by the usual methods.  I was ill, sometimes bed-ridden, for nearly 3 months.  My GP tested me for multiple causes including various forms of Lyme disease.  In late June my rheumatologist put me on a course of prednisone, which reduced the constant pain, brain fog, and exhaustion.  I have submitted info to the vaccine reporting system since getting the first vaccine and have responded to the followup contacts ever since.  I was contacted after reporting the adverse reaction, during the last followup contact.
At 12-00pm the pharmacist gave patient a J & J Covid Vaccine.  He asked him to sit down for 15 minutes.  At approximately 12-10PM Patient yelled for assistance. At the time the pharmacist ran over to the chair. Patient siaf that he was going to pass out. His eyes rolled back and it seemed like a seizure, at that point he began to pass out. The pharmacist assisted him to the floor. He was unresponsive on the floor for 10 seconds. After 10 seconds he regained consiouness. He said he felt fine. We called the ambulance. They came 15 minutes later. The pharmacist did his vitals pulse: 60 respirations:16 blood pressure 115/70. At that time the ambulance came and assisted him to the hospital.
Pale, Sweating, Shaking Nausea gave water, cool compress and chocolate had patient stay seated for 3- minutes then remain in store until feeling better Patient felt better and left of her own accord
Client received varicella vaccine 1/6/2014 at 1400. On 1/8/2014 in a.m. client noticed site of immunization swollen, warm and reddened.
pt broke out w/rash w/sl fever, itching 3 days;itch, red conjunctiva;
I woke up on Sunday 5/16 extremely exhausted and have not been able to get over it. It?s the same kind of exhaustion I had when I had covid but I don?t know if after the vaccine if it should be lasting this long. Nausea and exhaustion have been the only symptoms I have had but they didn?t start until 5/16 and I got the shot on 5/10
Headache, UrticariaPruritus, NauseaVomiting, Itching throat and neuropathy sensation over whole body  Narrative:  Other Relevant History:
administered with vaccine which was beyond the use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was beyond the use date) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067F21A) for COVID-19 vaccination.     No Medical History information was reported.    In December 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was beyond the use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was beyond the use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, single dose, subcutaneously; lot # and expiration date were not reported). On an unknown date, the patient experienced an unspecified autoimmune disorder. It was also reported that every month, since an unknown date, the patient got a shingle like sensation in her groin area. The outcome of the adverse events was unknown. The relatedness between the adverse events and ZOSTAVAX was not provided. Upon internal review, the adverse event of an unspecified autoimmune disorder was considered to be medically significant. This is one of two reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted.
Rapid heart rate, atrial fibrillation Lasting for over 6 hours Inflammation, redness, itchining, bump, soreness
No adverse effect reported; three year old patient was administered the first dose of VAQTA with the adult formulation; This spontaneous report was received from a Nurse refers to a 3 year old patient of unknown gender. The patient's concurrent condition, concomitant medication and medical history were unknown. On 08-APR-2019, the patient was vaccinated with first dose of hepatitis a vaccine, inactivated(VAQTA) vial (of lot # R006342 with expiry date 21-APR-2019) (strength, frequency, route of administration) with the adult formulation for prophylaxis (product administered to patient of inappropriate age). No adverse event was reported. The outcome of events was unknown. No product quality complaint involved.
Dizziness within 15 minutes of injection. Numbness face, jaws, (teeth) could not bite down. Mind and knees were 2 paces ahead of me when walking. Visual hallucinations. Questioned self about what dimension I was in - when dizzy later in day, I could look into brain, pinpoint area affected by dizziness, symbolized by feather - started at shaft of feather then I took BENADRYL that was neon green/blue/Eoke in color to the tip of feather. After seen by MD took BENADRYL home. Then drowsiness.
After taking the first dose 2 days ago (1/30/16) and today (2nd dose of vaccine), experienced diarrhea within 2-4 hours of taking the pill.  Stomach cramping as well, with 2nd dose today causing more severe effects, with more episodes.  Only one episode on 1/30, so didn't report immediately, but second pill creating multiple episodes of diarrhea today, so I called the doctor and decided to report it.
Expired vaccine was stored and then administered; Doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported. On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported.  Reporter stated that vaccine did not undergo any temperature excursion and patient did not experienced any adverse event and the date vaccine placed in refrigerator was on 04-Nov-2021.
ischemic stroke; This is a spontaneous report from a contactable consumer. A 9-decade-old (reported as: "in her 80's") female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration, first dose on 28Jan2021 at single dose for COVID-19 vaccination. Recent medical history included GI complications. The patient's concomitant medications were not reported. On 01Feb2021, the patient experienced ischemic stroke requiring hospitalization. Event took place after use of product. The outcome of the event was recovering.  Information about lot/batch number has been requested.
1wk p/vax in rt thigh a red sore area/tender appeared on exam, 11 days p/vax a minimally tender purple bruise was on outer rt thigh not cellulitis or indurated;
Patient described reddish rash the started at injection site and ran down arm towards elbow but not all the way to the elbow. She stated that it did not itch or hurt and that it had begun to resolve without extra medication. Her son did take her to her doctor for him to make sure that everything was ok.
redness and pain at the injection site; pain at the injection site; redness at the injection site; administered Flublok to a female patient who is 16 years and 10 months old; Initial information was received on 09-Oct-2020 regarding an unsolicited valid non-serious case from a pharmacist via phone.  This case involves a 16 years and 10 months old female patient who experienced redness and pain at the injection site (vaccination site inflammation with vaccination site pain and vaccination site erythema), while she received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not reported.   The patient did not receive other vaccine concomitantly.  On 07-Oct-2020, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot QFAA2047 and expiration date 30-Jun-2021) via an intramuscular route in the left arm for prophylactic vaccination.  On an unknown date, the patient developed non-serious redness and pain at the injection site (vaccination site inflammation with vaccination site pain and vaccination site erythema), (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Also, this was an actual medication error case due to inappropriate age at vaccine administration (latency was same day at the time of vaccination).  The pharmacist wanted to know if patient need to be revaccinated.  Details of laboratory data were not reported.  The patient was treated with IBUPROFEN for vaccination site inflammation .  At the time of reporting, outcome of the events was unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report was received from a physician concerning a 33 years old female patient who on 27-SEP-2012 was vaccinated with PNEUMOVAX 23, 0.5 mL "one shot every 10 years" (lot # H013581, expiration date in March 2014) for "chronic sinusitis". Concomitant medications included clindamycin, SINGULAIR and QNASL. On 28-SEP-2012, the patient experienced sepsis. The patient was sent to the emergency room (ER) and was hospitalized. The patient received treatment with intravenous (IV) antibiotics (unspecified), supportive IV fluids (unspecified) and TORADOL. On 01-OCT-2012, the patient recovered from sepsis and was discharged from the hospital. The relatedness for the event was unknown for PNEUMOVAX 23. Sepsis was considered to be immediately life-threatening by the reporting physician. Additional information has been requested.
Immediately following first does of covid vaccine patient became unresponsive, diaphortic. Pt did have a pulse and spontaneous breathing. Pt responded to ammonia  capsule by opening her eyes . She complained of sudden onset of chest and abdominal pain . Pt states she became dizzy, lightheaded immediately following the injection. Then developed chest tightness and abdominal pain and nausea . Pt rated abdominal pain 10 0n 1-10 scale. Pulse 88 resp 36 Tx at mobile clinic: Ammonia capsule, benadryl 25 mg PO Pts weight 40.1 kg Tx in ED: Prevacid , Tylenol with great relief ,symptoms resolved
Information has been received from a 27 year old female with no known allergies, with papilloma viral infection and a history of appendicitis who on 26-APR-2007 was vaccinated with Gardasil vaccine. Concomitant therapy included Paxil. After receiving her first dose in May 2007, the patient experienced loss of appetite. The patient did not seek medical attention. The patient's loss of appetite persisted. At the time of the report, the patient had received all 3 doses of Gardasil vaccine. Additional information has been requested.
Numbess, weakness, and "pins and needles" sensation that started in my left arm (injected arm) on 4/14/2021 and has not traveled to right arm, and both legs.
20min post vaccination patient complained of numbness of tongue, flushing, with hives on chest.  Patient was given 50mg of PO diphenhydramine and was monitored for 60 min.  Refused call to 911.   Flushing and warmth had abated and left clinic under own volition.
Itchy spots on head - hives days later, sores, severe pain on head from base of skull to top of head.  Went to doctor on 9/28 - Dr. prescribed Valacyclovir HCL. Have finished prescription - still itchy - occasional hives.
Pt recvd vax 18MAY92; sx of skin colored rash on neck w/pruritis, fatigue, weakness, & h/a on 20MAY92; had not seen MD: reports rash not red but becomes so if scratched;
I had foot pain from poor circulation, neuropathy, and swelling. I've had pain in my knees and upper and lower back. I use a walker for the pain. They gave me prednisone and methocarbamol one time. They gave me methylprednisolone and methocarbamol one time. I also used a TENS unit and stayed down as much as possible.
very fussy noc of vax;high pitched scream x 8hr day p/vax;
I want to report an adverse reaction to the Pfizer booster - 17 days after receiving the booster I noticed my neck was red; on my skin under my chin, on my throat area only.  Not itchy, just red and irritated.  A few days later slight raise in skin, and next day some linear rashes, like dashes on my neck - I had not changed anything in cosmetics, detergents, clothing fabrics (I am an allergic person so I examined all of that). My doctor said he had seen this and prescribed a cortisone cream to use and told me to take an antihistamine for a few days.  The rash is mostly gone now almost a week later.  Another friend had told me she also had a reaction 9 days after her booster; but hers was much more severe - having to go to the ER and is still 2 months later dealing with the issues.
Left upper arm swollen onset Saturday am 11/02/2002. Left upper arm from shoulder to elbow swollen, warm, and painful. ER sweeny 11/03/2002- warm compresses Rx Keflex Tylenol PrN
Mother brought infant in for 6 month old shots - reports that shots caused fever 104-105 degrees, lasting about nine hours - had cough and yellow nasal drainage next day only.  Mother gave Tylenol-did not seek medical advice.
Redness, warmth, pain over skin surrounding injection site c/w cellulitis. Treatment given: KEFLEX 500mg TID x 10d follow up 2 days.
Fever, papular erythematous rash with itching on face, arms and legs, 1 day, post vax. Alert and active. Being treated.
couldn't hear; her left ear canal is swollen; her ear was bothering her; This spontaneous case was reported by a consumer and describes the occurrence of EAR DISCOMFORT (her ear was bothering her), HYPOACUSIS (couldn't hear) and EAR SWELLING (her left ear canal is swollen) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included GABAPENTIN, OXYBUTYNIN, LOSARTAN POTASSIUM, RALOXIFENE, OMEPRAZOLE, ATORVASTATIN, COENZYME Q10 [UBIDECARENONE], CETIRIZINE, Vision health and CALCIUM, COLECALCIFEROL, MAGNESIUM (CALCIUM MAGNESIUM + VITAMIN D3) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced EAR DISCOMFORT (her ear was bothering her). On 16-Feb-2021, the patient experienced HYPOACUSIS (couldn't hear) and EAR SWELLING (her left ear canal is swollen). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICILLIN/CLAV POT) on 16-Feb-2021 for Ear swelling, at an unspecified dose and frequency. At the time of the report, EAR DISCOMFORT (her ear was bothering her), HYPOACUSIS (couldn't hear) and EAR SWELLING (her left ear canal is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
headache; fever; injection site pain; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced headache, fever and injection site pain on an unspecified date after his first dose of the vaccine. Outcome of the events was unknown. The events were assessed as non-serious.  Information on batch/lot number has been requested.
Information has been received on 08-JUL-2016 from a certified medical assistant referring to a patient of unknown age and gender. The patient's medical history and concomitant medications are unknown. On an unknown date the patient was vaccinated with VARIVAX lot # L034368, expiration date 08-SEP-2017 which was improperly stored for the indication. The temperature was reported as 43 degrees Fahrenheit for 5 days (120 hours). There was no previous temperature excursion. The call was due to a "data logger." No adverse effects were noted. Additional information has been requested.
Flu vaccine, unknown type. Cause fatigue,  body aches, chills, sneezing,  coughing, runny nose/eyes, allergic reaction around left eye (swelled close)
C/O heaviness and warmth to neck, shoulder, and back. C/O heart racing- HR 112. BP 143/99. ER diagnosed with allergic reaction- minor. Continue to report warmth and heaviness to mid-upper back.
The patient did not experience any symptoms.; the patient was administered one dose of ROTATEQ from a shipment that was received late (one day past the "must be received by date" on the box).; the patient was administered one dose of ROTATEQ from a shipment that was received late (one day past the "must be received by date" on the box).; This spontaneous report has been received from a registered nurse, referring to a patient of unknown age and gender. The patient's historical condition, concurrent condition and concomitant therapy were not reported.  On 16-JAN-2020, the patient received one dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot# 1660151 with expiration date: 17-SEP-2020; strength and frequency unknown) orally for prophylaxis, which was from a shipment that was received late (one day past the "must be received by date" on the box) (product distribution issue and inappropriate schedule of product administration). The patient did not experience any symptoms.
Local reaction(reddness) at site of varicella injectio.  Appeared the next morning and was still noticable 3 days later when pt returned to clinic for TB Skin test reading. Recommended warm compresses and tylenol.
After 3 shots done went to discard mom noticed he was starting to go pale and falling. I turned and caught Pt. and layed him on table. Doctor was called in and evaluated Pt he had gone pale, urinated on himself and eyes dilated. Pt given juice sat up for a while till color came back, Pt. puked. Doctor checked him, and after a while he was ok to leave.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 72-year-old female patient who received SHINGRIX for prophylaxis. On 26th March 2019, the patient received the 1st dose of SHINGRIX. On 27th March 2019, 1 days after receiving SHINGRIX, the patient experienced pain in arm and myalgia of lower extremities. On an unknown date, the outcome of the pain in arm and myalgia of lower extremities were not recovered/not resolved. It was unknown if the reporter considered the pain in arm and myalgia of lower extremities to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left arm. After vaccination, the patient experienced muscle pain in legs, upper thigh and little in claves. The left arm was sore. There was no consent to follow up.
injection in her knee and she was hurt by the injection; heart rate began to rise; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 18Feb2021 (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunisation; and cortisone (manufacturer unknown), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. Medical history included diabetes mellitus from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 28Jan2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient received Pfizer Covid-19 vaccine first dose on 28Jan2021, and 2nd dose on 18Feb2021. Four weeks later she received a cortisone injection in her knee, and she was hurt by the injection. Her heart rate began to rise, and she was wondering if that was from the Pfizer Covid-19 vaccine or from the Cortisone or from the diabetes. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number could not be requested.